NO20016089L - Nukleinsyrer og proteiner av det humane genet ABC1 - Google Patents

Nukleinsyrer og proteiner av det humane genet ABC1

Info

Publication number
NO20016089L
NO20016089L NO20016089A NO20016089A NO20016089L NO 20016089 L NO20016089 L NO 20016089L NO 20016089 A NO20016089 A NO 20016089A NO 20016089 A NO20016089 A NO 20016089A NO 20016089 L NO20016089 L NO 20016089L
Authority
NO
Norway
Prior art keywords
proteins
nucleic acids
human gene
abc1
gene abc1
Prior art date
Application number
NO20016089A
Other languages
English (en)
Norwegian (no)
Other versions
NO20016089D0 (no
Inventor
Patrice Denefle
Marie-Francoise Rosier-Montus
Isabelle Arnould-Reguigne
Catherine Prades
Laurent Naudin
Cendrine Lemoine
Nicolas Duverger
Gerd Assmann
Stephan Rust
Harald Funke
H Bryan Brewer
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9907684A external-priority patent/FR2795091B1/fr
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20016089D0 publication Critical patent/NO20016089D0/no
Publication of NO20016089L publication Critical patent/NO20016089L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Microbiology (AREA)
NO20016089A 1999-06-17 2001-12-13 Nukleinsyrer og proteiner av det humane genet ABC1 NO20016089L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9907684A FR2795091B1 (fr) 1999-06-17 1999-06-17 Acides nucleiques et proteines du gene abc1 humain et leur application en therapie et diagnostic
US14712899P 1999-08-04 1999-08-04
PCT/FR2000/001595 WO2000078970A1 (fr) 1999-06-17 2000-06-08 Acides nucleiques et proteines correspondant au gene abc1 humain

Publications (2)

Publication Number Publication Date
NO20016089D0 NO20016089D0 (no) 2001-12-13
NO20016089L true NO20016089L (no) 2002-02-15

Family

ID=26234994

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016089A NO20016089L (no) 1999-06-17 2001-12-13 Nukleinsyrer og proteiner av det humane genet ABC1

Country Status (11)

Country Link
EP (1) EP1190063A1 (fr)
JP (1) JP2003503026A (fr)
KR (1) KR20020012279A (fr)
AU (1) AU5540800A (fr)
BR (1) BR0011724A (fr)
CA (1) CA2375771A1 (fr)
HU (1) HUP0204524A2 (fr)
IL (1) IL147071A0 (fr)
MX (1) MXPA01013062A (fr)
NO (1) NO20016089L (fr)
WO (1) WO2000078970A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1100895B1 (fr) 1999-03-15 2007-06-13 University of British Columbia Methodes et reactifs permettant de moduler les taux de cholesterol
FR2815970A1 (fr) * 2000-10-31 2002-05-03 Aventis Pharma Sa Sequences polymorphes du gene humain abca1, leurs utilisations, les methodes et kits de detection
WO2002036770A2 (fr) * 2000-10-31 2002-05-10 Aventis Pharma S.A. Sequences polymorphes du gene humain abca1, leurs utilisations, les methodes et kits de detection
KR100623128B1 (ko) * 2002-01-02 2006-09-14 제넨테크, 인크. 종양의 진단 및 치료 방법 및 이를 위한 조성물
CN112442114A (zh) * 2019-08-29 2021-03-05 渥太华Hdl药物研发公司 一种多肽及其应用

Also Published As

Publication number Publication date
EP1190063A1 (fr) 2002-03-27
IL147071A0 (en) 2002-08-14
KR20020012279A (ko) 2002-02-15
MXPA01013062A (es) 2002-06-04
JP2003503026A (ja) 2003-01-28
BR0011724A (pt) 2002-03-26
AU5540800A (en) 2001-01-09
NO20016089D0 (no) 2001-12-13
HUP0204524A2 (hu) 2003-04-28
CA2375771A1 (fr) 2000-12-28
WO2000078970A1 (fr) 2000-12-28

Similar Documents

Publication Publication Date Title
EP1427746A4 (fr) Systemes d'expression de proteines et d'acides nucleiques
DK2325317T3 (da) Receptornukleinsyrer og polypeptidr
NO20013736L (no) Pyrazolkarboksylsyrederivater, deres fremstilling og farmasöytiske preparater inneholdende de samme
AU1339701A (en) Anti-cancer nucleic acid and protein targets
NO20015828L (no) Fremgangsmåter for fremstilling av 5'-nukleinsyre- proteinkonjugater
DE69819124D1 (de) Lyophilisation von kultivierten, menschlichen zellen zur konservierung der rna und dna
NO991839D0 (no) FremgangsmÕter og preparater for utlevering og ekspresjon av interferon-<alfa>-nukleinsyrer
NO20016089L (no) Nukleinsyrer og proteiner av det humane genet ABC1
EP1186615A4 (fr) Proteine et adn de cette proteine
HUP0400492A3 (en) Nucleic acids of the human abc1 gene and applications thereof
DK1330525T3 (da) NOD2-nukleinsyrer og proteiner
EE200200353A (et) Inimese heparanaasisarnane polüpeptiid ja nukleiinhape
IL160396A0 (en) Nucleic acids and proteins of insect or83b odorant receptor genes and uses thereof
GB2349150B (en) Expression of DNA or proteins in C. Elegans
EP1220896A4 (fr) Nouvelles proteines lipase humaines, acides nucleiques codant pour ces proteines, et leur utilisation
NO20021713L (no) Selv-kuttende RNA-sekvenser og deres anvendelse for kontroll av proteinsyntese
DE69913654D1 (de) Nachweis von Nukleinsäuren im Zytoplasma
WO2000065063A3 (fr) Vaccins a base d'acide nucleique contre les rickettsioses et utilisations
DK1721982T3 (da) Kimære lyssavirus nukleinsyrer og polypeptider
IL144849A0 (en) Angiopoietin-related protein and nucleic acids
AU3165500A (en) Human nucleic acid and protein sequences obtained from endothelial cells
ATE442591T1 (de) Krebsassoziierte nukleinsäure und proteine
AU2001278711A1 (en) Nucleic acids and proteins showing increased expression dose under salt stress
AU2002214669A1 (en) Isolated human transporter proteins nucleic acids and use thereof
AU2002351616A8 (en) Lipase genes and proteins

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application